| Authors: |
Ermann DA; Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA. daniel.ermann@hci.utah.edu., Stephens DM; University of North Carolina School of Medicine, Chapel Hill, NC, USA., Wang X; BeOne Medicines, Ltd, San Carlos, CA, USA., Varghese I; ADVI Health, Washington, DC, USA., De Souza H; ADVI Health, Washington, DC, USA., Sheetz C; ADVI Health, Washington, DC, USA., Fu Q; BeOne Medicines, Ltd, San Carlos, CA, USA., Maglinte GA; BeOne Medicines, Ltd, San Carlos, CA, USA., Williams R; BeOne Medicines, Ltd, San Carlos, CA, USA., Seymour EK; BeOne Medicines, Ltd, San Carlos, CA, USA., van Beuge D; BeOne Medicines, Ltd, San Carlos, CA, USA., Shadman M; Fred Hutchinson Cancer Center, University of Washington, Seattle, WA, USA., Jacobs R; Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC, USA. |
